FOR PHYSICIANS
Extending the treatment options
available to a complex case.
Vialen handles the foreign-access layer around a defined clinical question: record readiness, route verification, receiving-team coordination and return-home handoff.
International access is useful only when it adds a specific, verifiable option to the case.
Each case is defined by the treatment capability being considered, the records required for review and the next decision the evaluating institution must make.
WHAT HELPS DEFINE THE QUESTION
Diagnosis
Disease status
Prior treatment
Relevant biomarkers
Imaging
Current treatment decision
WHAT THE REVIEWING CENTER NEEDS TO DETERMINE
Potential relevance
Additional testing
Eligibility
Treatment-specific requirements
Whether the route can move forward
A USEFUL REVIEW SHOULD PRODUCE A DECISION
A useful review should clarify the clinical question and the appropriate next step.
A treatment-access review becomes useful when the evaluating clinical team can clarify what is relevant, what is still missing and whether the case should move further into a treatment-specific pathway.
01
Potential clinical relevance
Whether the treatment capability is reasonably relevant to the case.
02
Additional requirements
What pathology, imaging, testing or medical information is still required.
03
Eligibility direction
Whether further center-specific eligibility assessment is warranted.
04
Defined next action
What must happen next for the case to proceed, or why the route should stop.
Continuity matters across the treatment episode.
Where appropriate and available, clinical information can move between the patient’s existing physician and the evaluating treatment team before, during and after an international treatment episode.
LOCAL PHYSICIAN
→
EVALUATING CENTER
→
RETURN-OF-CARE CONTEXT
How a case moves through review
01
Define the clinical question
02
Prepare the relevant record set
03
Identify a credible treatment capability
04
Center-specific clinical review
05
Clarify next requirements
06
Move forward only if clinically appropriate
CLINICAL DECISION RIGHTS
Clinical interpretation, eligibility, treatment recommendation and medical decision-making remain with the relevant licensed physicians and treating institutions.